DMK PHARMACEUTICALS Corp Quarterly Depreciation in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
DMK PHARMACEUTICALS Corp quarterly/annual Depreciation history and growth rate from Q2 2010 to Q3 2023.
  • DMK PHARMACEUTICALS Corp Depreciation for the quarter ending September 30, 2023 was $67K, a 83.2% decline year-over-year.
  • DMK PHARMACEUTICALS Corp Depreciation for the twelve months ending September 30, 2023 was $636K, a 56.9% decline year-over-year.
  • DMK PHARMACEUTICALS Corp annual Depreciation for 2022 was $1.48M, a 3.34% increase from 2021.
  • DMK PHARMACEUTICALS Corp annual Depreciation for 2021 was $1.44M, a 9.79% increase from 2020.
  • DMK PHARMACEUTICALS Corp annual Depreciation for 2020 was $1.31M, a 119% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $636K $67K -$332K -83.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $968K $87K -$281K -76.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $1.25M $109K -$235K -68.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.48M $373K +$9K +2.47% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 $1.48M $399K +$24K +6.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.45M $368K -$1K -0.27% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 $1.45M $344K +$16K +4.88% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.44M $364K +$178K +95.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $1.26M $375K +$33K +9.65% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.23M $369K -$27K -6.82% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $1.25M $328K -$56K -14.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $1.31M $186K +$38K +25.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.27M $342K +$193K +130% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 $1.08M $396K +$251K +173% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-22
Q1 2020 $826K $384K +$228K +146% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-22
Q4 2019 $598K $148K -$12K -7.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 $610K $149K -$8K -5.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $618K $145K -$9K -5.84% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-17
Q1 2019 $627K $156K +$4K +2.63% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 $623K $160K +$34K +27% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $589K $157K +$18K +13% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $571K $154K -$5K -3.15% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $576K $152K -$12K -7.32% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $588K $126K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 $139K -$28.7K -17.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $159K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $164K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q3 2016 $168K Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-14
Q2 2010 $5.78K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.